Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	neurexin family protein binding	NLGN4Y NLGN4X SYTL3	5.94e-05	16	97	3	GO:0042043
GeneOntologyMolecularFunction	scaffold protein binding	NLGN4Y XIAP PANX1 GRIK2 NLGN4X	9.04e-05	93	97	5	GO:0097110
GeneOntologyCellularComponent	AP-3 adaptor complex	VPS18 AP3M1 AP3M2	2.68e-05	13	97	3	GO:0030123
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X	1.27e-04	4	97	2	GO:0098983
GeneOntologyCellularComponent	nuclear envelope	TOR1AIP2 NAPEPLD PARP8 IGF2R NXT1 OSBPL7 NAV3 CPNE1 TNKS2	1.18e-03	560	97	9	GO:0005635
GeneOntologyCellularComponent	AP-type membrane coat adaptor complex	VPS18 AP3M1 AP3M2	1.44e-03	48	97	3	GO:0030119
GeneOntologyCellularComponent	membrane coat	VPS18 AP3M1 IGF2R AP3M2	1.51e-03	106	97	4	GO:0030117
GeneOntologyCellularComponent	coated membrane	VPS18 AP3M1 IGF2R AP3M2	1.51e-03	106	97	4	GO:0048475
GeneOntologyCellularComponent	contractile actin filament bundle	XIRP1 SIPA1L3 CORO1B FSCN1	1.56e-03	107	97	4	GO:0097517
GeneOntologyCellularComponent	stress fiber	XIRP1 SIPA1L3 CORO1B FSCN1	1.56e-03	107	97	4	GO:0001725
GeneOntologyCellularComponent	symmetric synapse	NLGN4Y NLGN4X	1.61e-03	13	97	2	GO:0032280
GeneOntologyCellularComponent	Swr1 complex	EP400 SRCAP	1.61e-03	13	97	2	GO:0000812
GeneOntologyCellularComponent	neuron projection cytoplasm	GRIK2 AP3M1 OPRM1 AP3M2	1.73e-03	110	97	4	GO:0120111
GeneOntologyCellularComponent	trans-Golgi network membrane	SLC9A8 HLA-DRB1 IGF2R FUT9	1.85e-03	112	97	4	GO:0032588
GeneOntologyCellularComponent	actomyosin	XIRP1 SIPA1L3 CORO1B FSCN1	2.16e-03	117	97	4	GO:0042641
GeneOntologyCellularComponent	actin filament bundle	XIRP1 SIPA1L3 CORO1B FSCN1	2.23e-03	118	97	4	GO:0032432
GeneOntologyCellularComponent	clathrin coat	AP3M1 IGF2R AP3M2	2.25e-03	56	97	3	GO:0030118
MousePheno	increased pancreas weight	CTRB2 OPRM1 CTRB1	1.69e-05	11	67	3	MP:0009108
Domain	NLGN4	NLGN4Y NLGN4X	2.61e-05	2	96	2	IPR030025
Domain	WD_REPEATS_1	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2 EIF3B	9.32e-05	278	96	8	PS00678
Domain	WD_REPEATS_2	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2 EIF3B	9.55e-05	279	96	8	PS50082
Domain	WD_REPEATS_REGION	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2 EIF3B	9.55e-05	279	96	8	PS50294
Domain	ConA-like_dom	COL27A1 CLSTN2 SVEP1 CELSR2 NBEAL2 SEL1L3 USH2A	1.36e-04	219	96	7	IPR013320
Domain	HSA	EP400 SRCAP	1.56e-04	4	96	2	SM00573
Domain	HSA	EP400 SRCAP	1.56e-04	4	96	2	PS51204
Domain	HSA_dom	EP400 SRCAP	1.56e-04	4	96	2	IPR014012
Domain	HSA	EP400 SRCAP	1.56e-04	4	96	2	PF07529
Domain	Nlgn	NLGN4Y NLGN4X	2.59e-04	5	96	2	IPR000460
Domain	-	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2 EIF3B	3.19e-04	333	96	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2 EIF3B	3.32e-04	335	96	8	IPR015943
Domain	EGF_1	RELN SVEP1 SNED1 CELSR2 MEGF8 HYAL3 USH2A	3.46e-04	255	96	7	PS00022
Domain	WD40	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2	3.79e-04	259	96	7	PF00400
Domain	Clathrin_mu_CS	AP3M1 AP3M2	3.87e-04	6	96	2	IPR018240
Domain	CLAT_ADAPTOR_M_1	AP3M1 AP3M2	3.87e-04	6	96	2	PS00990
Domain	CLAT_ADAPTOR_M_2	AP3M1 AP3M2	3.87e-04	6	96	2	PS00991
Domain	hEGF	SVEP1 SNED1 CELSR2	3.93e-04	28	96	3	PF12661
Domain	WD40	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2	4.66e-04	268	96	7	SM00320
Domain	EGF_LAM_2	CELSR2 MEGF8 USH2A	4.83e-04	30	96	3	PS50027
Domain	EGF_LAM_1	CELSR2 MEGF8 USH2A	4.83e-04	30	96	3	PS01248
Domain	WD40_repeat	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2	5.08e-04	272	96	7	IPR001680
Domain	SNF2_N	EP400 CHD7 SRCAP	5.86e-04	32	96	3	IPR000330
Domain	SNF2_N	EP400 CHD7 SRCAP	5.86e-04	32	96	3	PF00176
Domain	Laminin_EGF	CELSR2 MEGF8 USH2A	7.64e-04	35	96	3	PF00053
Domain	EGF_Lam	CELSR2 MEGF8 USH2A	7.64e-04	35	96	3	SM00180
Domain	WD40_repeat_dom	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2	8.54e-04	297	96	7	IPR017986
Domain	LAM_G_DOMAIN	COL27A1 CELSR2 USH2A	9.74e-04	38	96	3	PS50025
Domain	Laminin_EGF	CELSR2 MEGF8 USH2A	9.74e-04	38	96	3	IPR002049
Domain	Clathrin_mu	AP3M1 AP3M2	1.15e-03	10	96	2	IPR001392
Domain	EGF_3	RELN SVEP1 SNED1 CELSR2 MEGF8 HYAL3	1.34e-03	235	96	6	PS50026
Domain	EGF	RELN SVEP1 SNED1 CELSR2 MEGF8 HYAL3	1.34e-03	235	96	6	SM00181
Domain	Adap_comp_sub	AP3M1 AP3M2	1.40e-03	11	96	2	PF00928
Domain	-	CLSTN2 SVEP1 CELSR2 USH2A	1.46e-03	95	96	4	2.60.120.200
Domain	Oxysterol-bd	OSBPL5 OSBPL7	1.67e-03	12	96	2	IPR000648
Domain	Oxysterol-bd_CS	OSBPL5 OSBPL7	1.67e-03	12	96	2	IPR018494
Domain	Clathrin_sm-chain_CS	AP3M1 AP3M2	1.67e-03	12	96	2	IPR000804
Domain	Oxysterol_BP	OSBPL5 OSBPL7	1.67e-03	12	96	2	PF01237
Domain	OSBP	OSBPL5 OSBPL7	1.67e-03	12	96	2	PS01013
Domain	ASX_HYDROXYL	SVEP1 SNED1 CELSR2 MEGF8	1.76e-03	100	96	4	PS00010
Domain	EGF-like_dom	RELN SVEP1 SNED1 CELSR2 MEGF8 HYAL3	1.80e-03	249	96	6	IPR000742
Domain	-	KBTBD6 KBTBD7 MEGF8	1.92e-03	48	96	3	2.120.10.80
Domain	MHD	AP3M1 AP3M2	1.97e-03	13	96	2	PS51072
Domain	MHD	AP3M1 AP3M2	1.97e-03	13	96	2	IPR028565
Domain	Carboxylesterase_B_CS	NLGN4Y NLGN4X	1.97e-03	13	96	2	IPR019819
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 SNED1 CELSR2 MEGF8	2.18e-03	106	96	4	IPR000152
Domain	EGF-like_CS	RELN SVEP1 SNED1 CELSR2 MEGF8 HYAL3	2.28e-03	261	96	6	IPR013032
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH9	2.29e-03	14	96	2	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH9	2.29e-03	14	96	2	IPR024743
Domain	CARBOXYLESTERASE_B_2	NLGN4Y NLGN4X	2.29e-03	14	96	2	PS00941
Domain	Dynein_heavy_dom-2	DNAH3 DNAH9	2.29e-03	14	96	2	IPR013602
Domain	DHC_N2	DNAH3 DNAH9	2.29e-03	14	96	2	PF08393
Domain	MT	DNAH3 DNAH9	2.29e-03	14	96	2	PF12777
Domain	AAA_8	DNAH3 DNAH9	2.29e-03	14	96	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH9	2.29e-03	14	96	2	IPR011704
Domain	COesterase	NLGN4Y NLGN4X	2.29e-03	14	96	2	PF00135
Domain	CarbesteraseB	NLGN4Y NLGN4X	2.29e-03	14	96	2	IPR002018
Domain	AAA_5	DNAH3 DNAH9	2.29e-03	14	96	2	PF07728
Domain	HELICASE_CTER	EP400 CHD7 SRCAP DHX32	2.42e-03	109	96	4	PS51194
Domain	HELICASE_ATP_BIND_1	EP400 CHD7 SRCAP DHX32	2.42e-03	109	96	4	PS51192
Domain	EGF_2	RELN SVEP1 SNED1 CELSR2 MEGF8 HYAL3	2.46e-03	265	96	6	PS01186
Domain	Helicase_ATP-bd	EP400 CHD7 SRCAP DHX32	2.50e-03	110	96	4	IPR014001
Domain	DHC_fam	DNAH3 DNAH9	2.63e-03	15	96	2	IPR026983
Domain	Dynein_heavy_dom	DNAH3 DNAH9	2.63e-03	15	96	2	IPR004273
Domain	Dynein_heavy	DNAH3 DNAH9	2.63e-03	15	96	2	PF03028
Domain	CCP	CSMD3 SVEP1 SNED1	2.70e-03	54	96	3	SM00032
Domain	Kelch-typ_b-propeller	KBTBD6 KBTBD7 MEGF8	2.85e-03	55	96	3	IPR015915
Domain	AP_mu_sigma_su	AP3M1 AP3M2	2.99e-03	16	96	2	IPR022775
Domain	Clat_adaptor_s	AP3M1 AP3M2	2.99e-03	16	96	2	PF01217
Domain	SUSHI	CSMD3 SVEP1 SNED1	3.00e-03	56	96	3	PS50923
Domain	Sushi_SCR_CCP_dom	CSMD3 SVEP1 SNED1	3.15e-03	57	96	3	IPR000436
Domain	Laminin_G	COL27A1 CELSR2 USH2A	3.31e-03	58	96	3	IPR001791
Domain	Poly(ADP-ribose)pol_cat_dom	PARP8 TNKS2	3.38e-03	17	96	2	IPR012317
Domain	PARP_CATALYTIC	PARP8 TNKS2	3.38e-03	17	96	2	PS51059
Domain	PARP	PARP8 TNKS2	3.38e-03	17	96	2	PF00644
Domain	-	PARP8 TNKS2	3.38e-03	17	96	2	3.90.228.10
Domain	Gal_Oxase/kelch_b-propeller	KBTBD6 KBTBD7 MEGF8	3.47e-03	59	96	3	IPR011043
Domain	EGF_CA	SVEP1 SNED1 CELSR2 MEGF8	3.62e-03	122	96	4	SM00179
Domain	EGF-like_Ca-bd_dom	SVEP1 SNED1 CELSR2 MEGF8	3.84e-03	124	96	4	IPR001881
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CCDC71L EP400 LONRF1 SIPA1L3 PANX1 CORO1B SRCAP IGF2R CELSR2 MEGF8 NBEAL2 OSBPL5 TRAPPC9 HR	3.03e-06	1105	99	14	35748872
Pubmed	Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice.	CTRB2 CTRB1	8.02e-06	2	99	2	30076839
Pubmed	The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.	CTRB2 CTRB1	8.02e-06	2	99	2	28951524
Pubmed	Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.	CTRB2 CTRB1	8.02e-06	2	99	2	28754779
Pubmed	Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.	CTRB2 CTRB1	8.02e-06	2	99	2	33036922
Pubmed	Evolutionary relationships between laboratory mice and subspecies of Mus musculus based on the restriction fragment length variants of the chymotrypsin gene at the Prt-2 locus.	CTRB2 CTRB1	8.02e-06	2	99	2	2565717
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	8.02e-06	2	99	2	18434543
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	8.02e-06	2	99	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	8.02e-06	2	99	2	24855039
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	8.02e-06	2	99	2	37001827
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	8.02e-06	2	99	2	37080762
Pubmed	Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.	CTRB2 CTRB1	8.02e-06	2	99	2	2917002
Pubmed	Genomic cloning and partial characterization of human chymotrypsinogen gene.	CTRB2 CTRB1	8.02e-06	2	99	2	8186414
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	8.02e-06	2	99	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	8.02e-06	2	99	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	8.02e-06	2	99	2	24104404
Pubmed	The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer.	EP400 SRCAP	8.02e-06	2	99	2	24507717
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	8.02e-06	2	99	2	32243781
Pubmed	Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.	GRIK2 NPAS2	8.02e-06	2	99	2	21912186
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	8.02e-06	2	99	2	22989184
Pubmed	RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.	OPRM1 RGS14	8.02e-06	2	99	2	17825524
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4Y NLGN4X	2.40e-05	3	99	2	32011705
Pubmed	Genetic study of pancreatic proteinase in mice (Mus musculus): linkage of the Prt-2 locus on chromosome 8.	CTRB2 CTRB1	2.40e-05	3	99	2	1016231
Pubmed	Secretagogue-induced pancreatitis in mice devoid of chymotrypsin.	CTRB2 CTRB1	2.40e-05	3	99	2	38981616
Pubmed	XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.	XIAP FSCN1	2.40e-05	3	99	2	28186968
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4Y NLGN4X	2.40e-05	3	99	2	18628683
Pubmed	Genetic study of pancreatic proteinase in mice (Mus musculus): genetic variants of trypsin and chymotrypsin.	CTRB2 CTRB1	2.40e-05	3	99	2	1008801
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4Y NLGN4X	2.40e-05	3	99	2	21282647
Pubmed	Evolutionary expansion of polyaspartate motif in the activation peptide of mouse cationic trypsinogen limits autoactivation and protects against pancreatitis.	CTRB2 CTRB1	2.40e-05	3	99	2	34643096
Pubmed	The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment.	KBTBD6 KBTBD7	2.40e-05	3	99	2	32572597
Pubmed	Loss of chymotrypsin-like protease (CTRL) alters intrapancreatic protease activation but not pancreatitis severity in mice.	CTRB2 CTRB1	2.40e-05	3	99	2	32678161
Pubmed	Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP.	EP400 SRCAP	4.79e-05	4	99	2	21673954
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4Y NLGN4X	4.79e-05	4	99	2	12669065
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4Y NLGN4X	4.79e-05	4	99	2	22671294
Pubmed	Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication.	NLGN4Y NLGN4X	4.79e-05	4	99	2	20579107
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN4Y NLGN4X	4.79e-05	4	99	2	16077734
Pubmed	Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations.	NLGN4Y NLGN4X	4.79e-05	4	99	2	17292328
Pubmed	Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease.	HLA-DRB1 CD40	4.79e-05	4	99	2	16279844
Pubmed	Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.	DNAH3 DNAH9	4.79e-05	4	99	2	11175280
Pubmed	RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling.	OPRM1 RGS20	7.98e-05	5	99	2	17126529
Pubmed	Genetic study of pancreatic proteinase and alpha-amylase in mice (Mus musculus).	CTRB2 CTRB1	7.98e-05	5	99	2	4461036
Pubmed	Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouse.	CTRB2 CTRB1	7.98e-05	5	99	2	6589791
Pubmed	Association analysis between schizophrenia and the AP-3 complex genes.	AP3M1 AP3M2	7.98e-05	5	99	2	19481122
Pubmed	Polymorphisms of candidate genes in Slovak autistic patients.	RELN NLGN4X	7.98e-05	5	99	2	20436377
Pubmed	LDL-cholesterol concentrations: a genome-wide association study.	TDRD15 CELSR2	7.98e-05	5	99	2	18262040
Pubmed	Neuroligins and neurexins link synaptic function to cognitive disease.	NLGN4Y NLGN4X	7.98e-05	5	99	2	18923512
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN4Y NLGN4X	7.98e-05	5	99	2	10996085
Pubmed	Genetic and biochemical characterization of a new chymotrypsin isozyme of the house mouse, CTRA-1.	CTRB2 CTRB1	7.98e-05	5	99	2	1820020
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN4Y NLGN4X	7.98e-05	5	99	2	37865312
Pubmed	A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population.	CLSTN2 NAV3 DNAH9	1.05e-04	32	99	3	23049088
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN4Y NLGN4X	1.19e-04	6	99	2	21838267
Pubmed	Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.	CTRB2 CTRB1	1.19e-04	6	99	2	23814066
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN4Y NLGN4X	1.19e-04	6	99	2	29724786
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EP400 G2E3 TRIM33 NBEAL2 OSBPL5 EFR3B CPNE1 KDM4A	1.39e-04	529	99	8	14621295
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	TNPO1 EP400 CHD7 CORO1B PWP1 TRIM33	1.61e-04	282	99	6	23667531
Pubmed	Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1.	HLA-DRB1 CD40	1.67e-04	7	99	2	20797713
Pubmed	Regulation of Wnt/PCP signaling through p97/VCP-KBTBD7-mediated Vangl ubiquitination and endoplasmic reticulum-associated degradation.	KBTBD6 KBTBD7	1.67e-04	7	99	2	33990333
Pubmed	Characterization of the adaptor-related protein complex, AP-3.	AP3M1 AP3M2	1.67e-04	7	99	2	9151686
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 EP400 CSMD3 WDR47 MEGF8 SEL1L3 NAV3	1.69e-04	407	99	7	12693553
Pubmed	WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy.	ARPC1B WDR47 PWP1	2.05e-04	40	99	3	29078390
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SLC9A8 NLGN4Y NAV3 EFR3B	2.12e-04	102	99	4	10231032
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	VPS18 EP400 OSBPL5 CERCAM	2.20e-04	103	99	4	10819331
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NLGN4Y NLGN4X	2.22e-04	8	99	2	30871858
Pubmed	Association of the AP-3 adaptor complex with clathrin.	AP3M1 AP3M2	2.22e-04	8	99	2	9545220
Pubmed	The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket.	OSBPL5 OSBPL7	2.22e-04	8	99	2	17428193
Pubmed	Isoform diversity in the Arp2/3 complex determines actin filament dynamics.	CORO1B ARPC1B	2.22e-04	8	99	2	26655834
Pubmed	A mouse gene of the paired-related homeobox class expressed in the caudal somite compartment and in the developing vertebral column, kidney and nervous system.	EIF3B FSCN1	2.22e-04	8	99	2	27747430
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	TOR1AIP2 CHD7 CORO1B TIPRL IGF2R	2.23e-04	191	99	5	31177093
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TNPO1 TOR1AIP2 POC1A DEF8 XIAP G2E3 CHD7 COX18 SRCAP AP3M1 IGF2R	2.65e-04	1084	99	11	11544199
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	CELSR2 MEGF8	2.85e-04	9	99	2	9693030
Pubmed	Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.	NLGN4Y NLGN4X	2.85e-04	9	99	2	23010509
Pubmed	Linkage and candidate gene studies of autism spectrum disorders in European populations.	RELN GRIK2	2.85e-04	9	99	2	20442744
Pubmed	Microglia ablation alleviates myelin-associated catatonic signs in mice.	NLGN4Y NLGN4X	2.85e-04	9	99	2	29252214
Pubmed	Identification of genes showing altered expression in preimplantation and early postimplantation parthenogenetic embryos.	ARPC1B IGF2R	2.85e-04	9	99	2	8565329
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	RELN WDR4 LONRF1 HLA-DRB1 SIPA1L3 DEF8 WDR47 TRIM33 NAV3 CERCAM KDM4A TNKS2	2.94e-04	1285	99	12	35914814
Pubmed	GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy.	MBOAT1 GRIK2	3.56e-04	10	99	2	25199915
Pubmed	The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.	XIAP CD40	3.56e-04	10	99	2	9384571
Pubmed	HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.	AP3M1 AP3M2	3.56e-04	10	99	2	18076669
Pubmed	Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.	HLA-DRB1 CLSTN2	4.34e-04	11	99	2	23472185
Pubmed	The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.	RELN CHD7	4.34e-04	11	99	2	28165338
Pubmed	The OSBP-related protein family in humans.	OSBPL5 OSBPL7	4.34e-04	11	99	2	11483621
Pubmed	A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.	HLA-DRB1 GUCY1B2	4.34e-04	11	99	2	24532677
Pubmed	CUL3-KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling.	KBTBD6 KBTBD7	4.34e-04	11	99	2	25684205
Pubmed	SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.	NLGN4Y NLGN4X	4.34e-04	11	99	2	32973045
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4Y NLGN4X	4.34e-04	11	99	2	26403076
Pubmed	A common variant in DRD3 receptor is associated with autism spectrum disorder.	RELN HLA-DRB1 OPRM1 NLGN4X	5.03e-04	128	99	4	19058789
Pubmed	A family of 12 human genes containing oxysterol-binding domains.	OSBPL5 OSBPL7	5.20e-04	12	99	2	11735225
Pubmed	An oxysterol-binding protein family identified in the mouse.	OSBPL5 OSBPL7	5.20e-04	12	99	2	12215260
Pubmed	Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.	HLA-DRB1 CD40	6.13e-04	13	99	2	19525955
Pubmed	N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso.	TRIM33 KDM4A	6.13e-04	13	99	2	14527417
Pubmed	Advancing the understanding of autism disease mechanisms through genetics.	NLGN4Y NLGN4X	6.13e-04	13	99	2	27050589
Pubmed	Characterization of a novel gene, sperm-tail-associated protein (Stap), in mouse post-meiotic testicular germ cells.	CTRB2 CTRB1	6.13e-04	13	99	2	11468771
Pubmed	An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases.	TOR1AIP2 KBTBD6 PWP1	6.48e-04	59	99	3	19295130
Pubmed	Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk.	HLA-DRB1 CD40	8.22e-04	15	99	2	20233754
Pubmed	Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function.	TNPO1 XIRP1	8.22e-04	15	99	2	26403541
Pubmed	Connexin Expression Is Altered in Liver Development of Yotari (dab1 -/-) Mice.	RELN PANX1	8.22e-04	15	99	2	34639052
Pubmed	Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism.	NLGN4Y NLGN4X	8.22e-04	15	99	2	18227507
Pubmed	Common variants at CD40 and other loci confer risk of rheumatoid arthritis.	HLA-DRB1 CD40	8.22e-04	15	99	2	18794853
Pubmed	Genetic variants in the prediction of rheumatoid arthritis.	HLA-DRB1 CD40	9.38e-04	16	99	2	20439292
Pubmed	Specific glial populations regulate hippocampal morphogenesis.	RELN GRIK2	9.38e-04	16	99	2	19020026
Cytoband	13q14.11	KBTBD6 KBTBD7 WBP4	8.40e-05	39	99	3	13q14.11
Cytoband	Ensembl 112 genes in cytogenetic band chr7q22	CCDC71L RELN NAPEPLD ZSCAN25 ARPC1B	1.17e-04	219	99	5	chr7q22
GeneFamily	WD repeat domain containing	POC1A WDR4 CORO1B ARPC1B WDR47 PWP1 NBEAL2	6.82e-05	262	70	7	362
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL5 OSBPL7	9.51e-04	12	70	2	670
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD3 SVEP1 SNED1	1.40e-03	57	70	3	1179
GeneFamily	Dyneins, axonemal	DNAH3 DNAH9	1.94e-03	17	70	2	536
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP8 TNKS2	1.94e-03	17	70	2	684
GeneFamily	Regulators of G-protein signaling	RGS14 RGS20	2.96e-03	21	70	2	720
Coexpression	GSE4142_NAIVE_VS_MEMORY_BCELL_UP	SLC39A2 WDR47 SNED1 TRIM33 CD40 AP3M2 CPNE1	9.44e-06	199	97	7	M6388
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH3 RELN CSMD3 NAV3 USH2A DNAH9	1.51e-06	159	99	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH3 RELN CSMD3 RGS20 USH2A DNAH9	1.75e-06	163	99	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	MIX23 KBTBD6 COL27A1 CLSTN2 PWP1 NAV3	2.08e-06	168	99	6	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	COVID-19_Moderate-B_memory\|World / disease group, cell group and cell class	UTS2B LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	3.11e-06	180	99	6	2f37187b866edb56410c2334b72713f2248dc335
ToppCell	COVID-19_Moderate-B_memory\|COVID-19_Moderate / disease group, cell group and cell class	UTS2B LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	3.31e-06	182	99	6	bbdbef62389ac062118cc0c7979686393399f2c8
ToppCell	ICU-SEP-Lymphocyte-B-B_memory\|ICU-SEP / Disease, Lineage and Cell Type	UTS2B LYPLAL1 NLGN4Y HLA-DRB1 CD40 SEL1L3	3.99e-06	188	99	6	b6d81be72bbd72a68722ab51d1a72c436ef9bc17
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LYPLAL1 HLA-DRB1 DEF8 ARPC1B CD40 SEL1L3	4.92e-06	195	99	6	cccc9c70bb8f6df8c6ab94534c17475af1d3e224
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 PWP1 SNED1 CD40 SEL1L3 EIF3B	5.07e-06	196	99	6	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	MS-IIF-Lymphocyte-B-B_memory\|IIF / Disease, condition lineage and cell class	LYPLAL1 HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	5.37e-06	198	99	6	ae6f1d3ca7d7aa6f6f45b6b51aa8a967cadde017
ToppCell	Sepsis-ICU-SEP-Lymphocyte-B-B_memory\|ICU-SEP / Disease, condition lineage and cell class	UTS2B LYPLAL1 NLGN4Y HLA-DRB1 CD40 SEL1L3	5.37e-06	198	99	6	4ba2eb32889bbf043f4bbb822e08eb45a2b576ef
ToppCell	mild-B_memory\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UTS2B LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	5.53e-06	199	99	6	025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory\|COVID-19_Mild / Disease, condition lineage and cell class	LYPLAL1 HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	5.53e-06	199	99	6	54e392b4ebe601d4838739ff7de3ac6b2203c948
ToppCell	Sepsis-Int-URO-Lymphocyte-B-B_memory\|Int-URO / Disease, condition lineage and cell class	UTS2B LYPLAL1 HLA-DRB1 RGS20 CD40 SEL1L3	5.53e-06	199	99	6	7cddf15aeb65df17f737bb3144d6579ec5a1ea27
ToppCell	COVID-19-kidney-Mito-rich_Int\|kidney / Disease (COVID-19 only), tissue and cell type	RELN CSMD3 SVEP1 CTRB1 DNAH9	1.03e-05	129	99	5	57b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 LRRC9 FAM227A USH2A DNAH9	2.43e-05	154	99	5	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 LRRC9 FAM227A USH2A DNAH9	2.43e-05	154	99	5	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	PARP8 SYTL3 AP3M2 FAM227A DNAH9	2.58e-05	156	99	5	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	DNAH3 CTRB2 GRIK2 NLGN4X FSCN1	2.75e-05	158	99	5	ab05f6d7968ccd6d3826cd71b763dbedc83822c3
ToppCell	facs-Marrow-B-cells-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SLC39A2 SEL1L3 FSCN1 HR	3.38e-05	165	99	5	361a605d8f833d9ec54b120480dce397da35f9c3
ToppCell	3'_v3-blood-Lymphocytic_B-ABC_aged-B_memory\|blood / Manually curated celltypes from each tissue	UTS2B HLA-DRB1 INSL6 CD40 SEL1L3	3.68e-05	168	99	5	2ce1a30feb2704a9516d1dab161a26cb0555abb5
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 LRRC9 SNED1 FAM227A DNAH9	3.79e-05	169	99	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NAPEPLD CLSTN2 SEL1L3 FUT9 CERCAM	3.90e-05	170	99	5	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	Bac-SEP-Lymphocyte-B-B_memory\|Bac-SEP / Disease, Lineage and Cell Type	UTS2B LYPLAL1 HLA-DRB1 CD40 SEL1L3	3.90e-05	170	99	5	86db153984437ef1447eae8ef30a40be0925ffd5
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS9 G2E3 AP3M1 HYAL3 TUBAL3	4.24e-05	173	99	5	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS9 G2E3 AP3M1 HYAL3 TUBAL3	4.24e-05	173	99	5	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	wk_20-22-Epithelial-PNS\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RELN GRIK2 CLSTN2 NLGN4X HR	4.24e-05	173	99	5	17b1a6b0318925d5d920f2c0a791745b9587ebef
ToppCell	PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RELN GRIK2 ARPC1B NLGN4X HR	4.35e-05	174	99	5	0d8e737860120dcd3a6b57992c612595904d585e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y GRIK2 SVEP1 NLGN4X HR	4.35e-05	174	99	5	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y GRIK2 SVEP1 NLGN4X HR	4.35e-05	174	99	5	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LYPLAL1 HLA-DRB1 DEF8 CD40 SEL1L3	4.35e-05	174	99	5	fde40c5d51f5380088360dc5a583eb04e518deb6
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL27A1 INSL6 CD40 KDM4A FSCN1	4.47e-05	175	99	5	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	IIF-Lymphocyte-B-B_intermediate\|IIF / Disease, Lineage and Cell Type	UTS2B HLA-DRB1 SIPA1L3 CD40 SEL1L3	4.47e-05	175	99	5	327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRIK2 CSMD3 CTRB1 USH2A DNAH9	4.47e-05	175	99	5	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL27A1 CHD7 INSL6 CERCAM FSCN1	4.60e-05	176	99	5	24b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCell	facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SLC39A2 SEL1L3 FSCN1 HR	4.60e-05	176	99	5	5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCell	wk_20-22-Epithelial-PNS-Late_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RELN GRIK2 CLSTN2 NLGN4X HR	4.60e-05	176	99	5	81924471d8a8c5bd8eedf294c007e25b6cd3e417
ToppCell	BAL-Mild-cDC_3\|Mild / Compartment, Disease Groups and Clusters	ZSCAN25 KBTBD7 RGS14 OSBPL7 CERCAM	4.60e-05	176	99	5	f9b0c3ced391e7ebe6b242d3f12ba14741f88d22
ToppCell	wk_15-18-Epithelial-PNS-Schwann_precursor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TMPRSS9 GRIK2 CHD7 NLGN4X CELSR2	4.72e-05	177	99	5	5357359e6c2161a37f39a6b3b78449f5cbc327d1
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL27A1 CHD7 INSL6 CERCAM FSCN1	4.72e-05	177	99	5	f360f7099570d248531897b96e0de282e58f59e9
ToppCell	facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SLC39A2 SEL1L3 FSCN1 HR	4.72e-05	177	99	5	35d42b07d9c31528bf59199e361bb8a3bfbe3b75
ToppCell	PCW_13-14-Neuronal-Neuronal_SCP\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RELN GRIK2 ARPC1B NLGN4X HR	4.72e-05	177	99	5	621dd82f1393c961d4dd7a615aa52c9df9e36336
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ\|normal_Lymph_Node / Location, Cell class and cell subclass	LYPLAL1 HLA-DRB1 DEF8 CD40 SEL1L3	4.85e-05	178	99	5	d75057e7463558a0d3cebde3c30befbf4704dd9a
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMPRSS9 COL27A1 SVEP1 SNED1 NAV3	5.12e-05	180	99	5	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	10x5'-Liver-Lymphocytic_B-Memory_B_cells\|Liver / Manually curated celltypes from each tissue	UTS2B HLA-DRB1 NLGN4X CD40 SEL1L3	5.25e-05	181	99	5	a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	NLGN4Y HLA-DRB1 CHD7 CD40 SEL1L3	5.39e-05	182	99	5	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 SIPA1L3 CLSTN2 CD40 SEL1L3	5.39e-05	182	99	5	ccd729388d997cc45071175cb0c3db6d0790eaf8
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN CLSTN2 ARPC1B CELSR2 HR	5.53e-05	183	99	5	547b1fb9f9940cfc8d6e351d96acc0da44def57e
ToppCell	Control-Lymphocyte-B-B_memory\|Control / Disease, Lineage and Cell Type	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	5.53e-05	183	99	5	491fa04a1d2caeeec6c6403c9a38b4a1257fc2bc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CSMD3 NAV3 USH2A DNAH9	5.68e-05	184	99	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CSMD3 NAV3 USH2A DNAH9	5.68e-05	184	99	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Healthy/Control-B_memory\|World / Disease group and Cell class	UTS2B LYPLAL1 CHD7 CD40 SEL1L3	5.68e-05	184	99	5	9e1879d86b535ede9b47deb0752e291f987a5d5e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CSMD3 NAV3 USH2A DNAH9	5.68e-05	184	99	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	IIF-Lymphocyte-B-B_memory\|IIF / Disease, Lineage and Cell Type	LYPLAL1 HLA-DRB1 PWP1 CD40 SEL1L3	5.82e-05	185	99	5	c0eeab45c4ddefe107690a4ba8868fed2962c730
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	5.82e-05	185	99	5	38e07b3f846f8a929c22424a526b69bf66e0b220
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 RGS14 INSL6 SYTL3 DNAH9	5.98e-05	186	99	5	02fbb02c495e7d64c4ab50e42e5197782f2c0816
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMPRSS9 CHD7 ARPC1B CELSR2 FSCN1	5.98e-05	186	99	5	76535681667c8afb884fa72b6edfee9e1e46335b
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	B3GALT5 GRIK2 SEL1L3 FUT9 NPAS2	6.13e-05	187	99	5	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	UTS2B LYPLAL1 HLA-DRB1 CD40 SEL1L3	6.13e-05	187	99	5	ea56cfca919a09db852b7ee5e42323f822962465
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HLA-DRB1 SIPA1L3 SNED1 CD40 SEL1L3	6.13e-05	187	99	5	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	UTS2B LYPLAL1 HLA-DRB1 CD40 SEL1L3	6.13e-05	187	99	5	43f81863063509337bd56a67010c62fb51109bd5
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HLA-DRB1 SIPA1L3 SNED1 CD40 SEL1L3	6.13e-05	187	99	5	af1327559f7e01bec070881cae52834917c3da65
ToppCell	Multiple_Sclerosis-Lymphocyte-B-B_memory\|Multiple_Sclerosis / Disease, Lineage and Cell Type	UTS2B LYPLAL1 HLA-DRB1 CD40 SEL1L3	6.29e-05	188	99	5	8da631b2c75441b7309f03e7d4c14f15f2367be6
ToppCell	Control-Lymphoid_B-B_memory\|Control / Disease group, lineage and cell class	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.29e-05	188	99	5	ba4245de3bee29118abab57c4fce60b2007a189c
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SLC22A24 CD40 SEL1L3 NAV3 NPAS2	6.29e-05	188	99	5	b9c5d573fc5ab0f7f38c55d006f9576634b05462
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UTS2B LYPLAL1 HLA-DRB1 CD40 SEL1L3	6.29e-05	188	99	5	b6ae707b033a17c75ca81f9194631ead1b63d170
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.29e-05	188	99	5	cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.29e-05	188	99	5	9256c5f45c97df209bb9c322c3b557d4f726a333
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.44e-05	189	99	5	ac0203f17b481d608587113ea2de0f383b29ed27
ToppCell	remission-B_memory\|World / disease stage, cell group and cell class	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.61e-05	190	99	5	c3f55f752e47b5a71e111367cdbed4a39ab5cb21
ToppCell	wk_08-11-Epithelial-PNS-Schwann_precursor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TMPRSS9 GRIK2 CHD7 NLGN4X FSCN1	6.61e-05	190	99	5	4a777d8aa19cadd3b61b023772df142421a89113
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HLA-DRB1 SIPA1L3 SNED1 CD40 SEL1L3	6.61e-05	190	99	5	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.77e-05	191	99	5	03f6da73e7b706252d2096507222229c4101a27b
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.77e-05	191	99	5	578b58782e816ecaeabfbc616ceb1dcd53ee428b
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KBTBD6 CSMD3 KBTBD7 IGF2R NBEAL2	6.77e-05	191	99	5	d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.77e-05	191	99	5	22134a2c1a92208bc1629a620ce73a56502613c2
ToppCell	severe_COVID-19-B_memory\|World / disease group, cell group and cell class (v2)	UTS2B HLA-DRB1 CHD7 CD40 SEL1L3	6.77e-05	191	99	5	3b57e353b74ebc866d0e11deeba31fa764c42325
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DRB1 SIPA1L3 CHD7 CD40 SEL1L3	6.77e-05	191	99	5	5a9a592875fbd0b1429b48db29a760fdc9c2c856
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 SIPA1L3 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	75ce635d669ff77d1fd54e10467f21d5e5d67b08
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	UTS2B LYPLAL1 HLA-DRB1 CD40 SEL1L3	6.94e-05	192	99	5	185dd150d3345cd29625052a46f3ed89f2a9a8f6
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	debd471f61cf3606b8e9c246add0be5df601af7f
ToppCell	control-B_memory\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	d6ef271b6c4f9b49323650f3f773abd61c1b13c3
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	80a71ab3434076803466ccac0df73468889c7dd3
ToppCell	COVID-19_Mild-Lymphoid_B-B_memory\|COVID-19_Mild / Disease group, lineage and cell class	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	d27db7669de95bddbea8ccb83e6f10ae7240b1ab
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	6.94e-05	192	99	5	314f74dd3c6d94839eed05b9a1a398217ef78029
ToppCell	IPF-Lymphoid-T\|World / Disease state, Lineage and Cell class	PARP8 CORO1B OPRM1 SYTL3 AP3M2	6.94e-05	192	99	5	b25ba1f3bc842c22602b2aeed3b1b5082863e4fa
ToppCell	Healthy_donor-B_intermediate\|World / disease group, cell group and cell class (v2)	TDRD15 UTS2B HLA-DRB1 CD40 SEL1L3	6.94e-05	192	99	5	f77007b284e11f8654ad599eef929df7c6c4ebf0
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DRB1 SIPA1L3 CHD7 CD40 SEL1L3	7.11e-05	193	99	5	7cc10e8b51091869d46e462f3214999e7b5348b1
ToppCell	mild_COVID-19-B_memory\|World / disease group, cell group and cell class (v2)	HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	7.11e-05	193	99	5	69b70c838328fdc7dbb6b5449fe2811a5389a839
ToppCell	mild_COVID-19-B_memory\|mild_COVID-19 / disease group, cell group and cell class (v2)	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	7.11e-05	193	99	5	7e6fe70928a50b0a8f12220e572c07c5670d092e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	TNPO1 XIAP G2E3 TRIM33 IGF2R	7.11e-05	193	99	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	7.11e-05	193	99	5	ac227ddabfb3f021b1b39dba73f898517cd5a58e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	LYPLAL1 HLA-DRB1 PWP1 CD40 SEL1L3	7.11e-05	193	99	5	9f798a1bbd9f076c3122d02ed28418c18bb7a369
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	7.11e-05	193	99	5	f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 CHD7 PWP1 CD40 SEL1L3	7.29e-05	194	99	5	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DRB1 SIPA1L3 CHD7 CD40 SEL1L3	7.29e-05	194	99	5	2b61023a602d336ed0de174e9141046173db34e6
ToppCell	COVID-19_Mild-Lymphoid_B-B_intermediate\|COVID-19_Mild / Disease group, lineage and cell class	HLA-DRB1 SIPA1L3 CHD7 CD40 SEL1L3	7.29e-05	194	99	5	bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DRB1 SIPA1L3 CHD7 CD40 SEL1L3	7.29e-05	194	99	5	f2486b19ac52a48d19f80b38a5536bee3dad745b
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LYPLAL1 HLA-DRB1 CHD7 CD40 SEL1L3	7.29e-05	194	99	5	40c7f9bd69a8e843b81972e25a67f591021415dd
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 PWP1 CD40 SEL1L3 EIF3B	7.47e-05	195	99	5	a4d36654b968acb1aea252ac203683939461f1d1
Drug	Uroguanylin	SLC39A2 CTRB2 GUCY1B2 CTRB1	1.64e-05	36	97	4	CID005488765
Drug	c189	CTRB2 CTRB1	1.80e-05	2	97	2	CID000248048
Drug	BOCPheONP	CTRB2 CTRB1	1.80e-05	2	97	2	CID000111308
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	1.80e-05	2	97	2	CID000191369
Drug	MPM-06	CTRB2 CTRB1	1.80e-05	2	97	2	CID000161546
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	1.80e-05	2	97	2	CID011820300
Drug	NSC-374899	CTRB2 CTRB1	1.80e-05	2	97	2	CID000435726
Drug	5-aminotetrazole	CTRB2 CTRB1	1.80e-05	2	97	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	1.80e-05	2	97	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	1.80e-05	2	97	2	CID000122753
Drug	methylbenzenebutanoate	CTRB2 CTRB1	1.80e-05	2	97	2	CID000281254
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	1.80e-05	2	97	2	CID000191275
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	1.80e-05	2	97	2	CID004418081
Drug	isobutyl sulfide	CTRB2 CTRB1	1.80e-05	2	97	2	CID000011607
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	WDR4 SIPA1L3 GRIK2 SRCAP RGS14 MEGF8 CD40	2.10e-05	196	97	7	4574_DN
Drug	zLYCK	NAPEPLD CTRB2 CTRB1	4.03e-05	16	97	3	CID000171556
Drug	3-amino-2-pyridone	CTRB2 CTRB1	5.37e-05	3	97	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	5.37e-05	3	97	2	CID003035649
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	5.37e-05	3	97	2	CID000070396
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	5.37e-05	3	97	2	CID000087784
Drug	Z-Phe-OMe	CTRB2 CTRB1	5.37e-05	3	97	2	CID003082435
Drug	photophor	CTRB2 CTRB1	5.37e-05	3	97	2	CID000014780
Drug	3-methylcoumarin	CTRB2 CTRB1	5.37e-05	3	97	2	CID000017130
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	5.37e-05	3	97	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	5.37e-05	3	97	2	CID004309911
Drug	2-propyl methylphosphonochloridate	CTRB2 CTRB1	5.37e-05	3	97	2	CID000102124
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	5.37e-05	3	97	2	CID000171547
Drug	AFMeq	CTRB2 CTRB1	5.37e-05	3	97	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	5.37e-05	3	97	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	5.37e-05	3	97	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	5.37e-05	3	97	2	CID000152933
Drug	FK-316	CTRB2 CTRB1	5.37e-05	3	97	2	CID000133688
Drug	AC1L19T8	CTRB2 CTRB1	5.37e-05	3	97	2	CID000000694
Drug	Marinostatin D	CTRB2 CTRB1	5.37e-05	3	97	2	CID000132206
Drug	c140	CTRB2 CTRB1	5.37e-05	3	97	2	CID002783250
Drug	1FD7	CTRB2 CTRB1	5.37e-05	3	97	2	CID000445579
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	5.37e-05	3	97	2	CID000127677
Drug	phenyl hippurate	CTRB2 CTRB1	5.37e-05	3	97	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	5.37e-05	3	97	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	5.37e-05	3	97	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	5.37e-05	3	97	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	5.37e-05	3	97	2	CID000328214
Drug	Glt-leu-phe-nh-meq	CTRB2 CTRB1	5.37e-05	3	97	2	CID000194914
Drug	AC1L4Z4F	CTRB2 CTRB1	5.37e-05	3	97	2	CID000194913
Drug	Glt-Phe-NH-FMeq	CTRB2 CTRB1	5.37e-05	3	97	2	CID000194912
Drug	C18 4	CTRB2 CTRB1	5.37e-05	3	97	2	CID000077248
Drug	diacetyl trimer	CTRB2 CTRB1	5.37e-05	3	97	2	CID000193527
Drug	FK-448	CTRB2 CTRB1	5.37e-05	3	97	2	CID006917869
Drug	Ac-Phe-OMe	CTRB2 CTRB1	5.37e-05	3	97	2	CID000097805
Drug	taraxastane	CTRB2 CTRB1	5.37e-05	3	97	2	CID006429404
Drug	thiobenzyl N-heptafluorobutyrylanthranilate	CTRB2 CTRB1	5.37e-05	3	97	2	CID000133906
Drug	Phe-phe-ome	CTRB2 CTRB1	5.37e-05	3	97	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	5.37e-05	3	97	2	CID000065389
Drug	acetyltryptophanamide	CTRB2 CLSTN2 CTRB1	9.43e-05	21	97	3	CID000002003
Drug	Benzoyl-dl-leucine	CTRB2 CTRB1	1.07e-04	4	97	2	CID000294887
Drug	Acafcek	CTRB2 CTRB1	1.07e-04	4	97	2	CID000197677
Drug	p-fluorobenzenesulfonyl chloride	CTRB2 CTRB1	1.07e-04	4	97	2	CID000009588
Drug	BSSDA	CTRB2 CTRB1	1.07e-04	4	97	2	CID003081106
Drug	B-1,3-od	CTRB2 CTRB1	1.07e-04	4	97	2	CID011971053
Drug	AC1L2HV6	CTRB2 CTRB1	1.07e-04	4	97	2	CID000047328
Drug	dehydromerodesmosine	CTRB2 CTRB1	1.07e-04	4	97	2	CID006443540
Drug	AC1L4X1Z	CTRB2 CTRB1	1.07e-04	4	97	2	CID000193815
Drug	alpha-amyrin palmitate	CTRB2 CTRB1	1.07e-04	4	97	2	CID000185477
Drug	poly-THIQ	CTRB2 CTRB1	1.07e-04	4	97	2	CID006453487
Drug	NSC-676827	CTRB2 CTRB1	1.07e-04	4	97	2	CID000385555
Drug	N-(4-carboxycyclohexylmethyl)-maleimide	CTRB2 CTRB1	1.07e-04	4	97	2	CID011548799
Drug	G2505_sigma	CTRB2 CTRB1	1.07e-04	4	97	2	CID000111098
Drug	6-amino-1,2-benzopyrone	CTRB2 CTRB1	1.07e-04	4	97	2	CID000046152
Drug	nitrophenylethanol	CTRB2 CTRB1	1.07e-04	4	97	2	CID000097851
Drug	ethanolamine-O-sulfate	CTRB2 PANX1 FSCN1 CTRB1	1.34e-04	61	97	4	CID000070223
Drug	7-chloro-4-nitrobenzofuran	CTRB2 CTRB1	1.78e-04	5	97	2	CID000130782
Drug	Ac-Trp-OEt	CTRB2 CTRB1	1.78e-04	5	97	2	CID000304749
Drug	Z-Phe-Leu	CTRB2 CTRB1	1.78e-04	5	97	2	CID000333351
Drug	5'-FSBAzA	CTRB2 CTRB1	1.78e-04	5	97	2	CID000130430
Drug	AC1L3F57	CTRB2 CTRB1	1.78e-04	5	97	2	CID000139565
Drug	apne	CTRB2 CTRB1	1.78e-04	5	97	2	CID000098192
Drug	3,5-dimethylpyrazole-1-carboxamidine	CTRB2 CTRB1	1.78e-04	5	97	2	CID000097525
Drug	Maap-borov	CTRB2 CTRB1	1.78e-04	5	97	2	CID005486914
Drug	2-amino-4,6-dichlorotriazine	CTRB2 CTRB1	1.78e-04	5	97	2	CID000013615
Drug	AC1O52A0	CTRB2 CTRB1	1.78e-04	5	97	2	CID006475891
Drug	allysine aldol	CTRB2 CTRB1	1.78e-04	5	97	2	CID000191270
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A	SLC9A8 SIPA1L3 DEF8 SRCAP NBEAL2 TNKS2	1.84e-04	194	97	6	1422_UP
Drug	Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A	EFCAB11 PARP8 GRIK2 RGS14 CD40 HR	1.84e-04	194	97	6	4786_UP
Drug	AC1L9M3D	CTRB2 OTC CTRB1	2.04e-04	27	97	3	CID000448563
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	SLC9A8 WDR4 SIPA1L3 CHD7 SRCAP NBEAL2	2.05e-04	198	97	6	7549_UP
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	RELN SRCAP RGS14 MEGF8 EFR3B HR	2.05e-04	198	97	6	6079_UP
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	WDR4 EP400 WBP4 CD40 FSCN1 ALDH6A1	2.11e-04	199	97	6	4795_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ZHX3 SVEP1 SNED1 CD40 EFR3B NPAS2	2.11e-04	199	97	6	3205_UP
Drug	conta-1(35),3,5,7(37),8,10,12,15,32(36),33-decaene-30-carboxylic acid	CTRB2 OPRM1 TAS1R2 CTRB1	2.55e-04	72	97	4	CID000489933
Drug	octyl isocyanate	CTRB2 CTRB1	2.66e-04	6	97	2	CID000076616
Drug	Asp-Asp-Asp-Asp	CTRB2 CTRB1	2.66e-04	6	97	2	CID004432006
Drug	N-benzoyl-L-tyrosine thiobenzyl ester	CTRB2 CTRB1	2.66e-04	6	97	2	CID000191444
Drug	Leupeptin acid	CTRB2 CTRB1	2.66e-04	6	97	2	CID000189069
Drug	Sri 8835	CTRB2 CTRB1	2.66e-04	6	97	2	CID000479975
Drug	N,N-dimethylglycylbenzocaine	CTRB2 CTRB1	2.66e-04	6	97	2	CID000188251
Drug	N-benzoyltyrosine butylamide	CTRB2 CTRB1	2.66e-04	6	97	2	CID000125261
Drug	D-gluconyl-glycine azide	CTRB2 CTRB1	2.66e-04	6	97	2	CID000194550
Drug	2-azidoatrazine	CTRB2 CTRB1	2.66e-04	6	97	2	CID003032432
Drug	L-659,286	CTRB2 CTRB1	2.66e-04	6	97	2	CID000128954
Drug	bz-Ala-OMe	CTRB2 CTRB1	2.66e-04	6	97	2	CID000023671
Disease	triglycerides in IDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2 TNKS2	1.38e-06	58	97	5	EFO_0022149
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2 CPNE1 TNKS2	8.47e-06	220	97	7	EFO_0004529, EFO_0008317
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	1.07e-05	2	97	2	OBA_2041192
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2 CPNE1 TNKS2	1.10e-05	229	97	7	EFO_0004639, EFO_0008317
Disease	triglycerides in large LDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	1.23e-05	43	97	4	EFO_0022319
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2 TNKS2	1.87e-05	166	97	6	EFO_0004530, EFO_0004611
Disease	phospholipids in medium LDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	2.08e-05	49	97	4	EFO_0022183
Disease	total lipids in LDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	2.63e-05	52	97	4	EFO_0022308
Disease	total lipids in medium VLDL	TDRD15 HLA-DRB1 IGF2R CELSR2	3.06e-05	54	97	4	EFO_0022153
Disease	peripheral arterial disease	HLA-DRB1 CSMD3 CELSR2 SYTL3	3.06e-05	54	97	4	EFO_0004265
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	3.20e-05	3	97	2	EFO_0801477
Disease	triglyceride measurement, intermediate density lipoprotein measurement	HLA-DRB1 IGF2R CELSR2 CPNE1 TNKS2	3.37e-05	111	97	5	EFO_0004530, EFO_0008595
Disease	triglycerides in LDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	3.53e-05	56	97	4	EFO_0022320
Disease	phospholipids in VLDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	4.35e-05	59	97	4	EFO_0022301
Disease	total lipids in VLDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	4.65e-05	60	97	4	EFO_0022314
Disease	free cholesterol in VLDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	4.96e-05	61	97	4	EFO_0022276
Disease	triglycerides in medium LDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	5.29e-05	62	97	4	EFO_0022322
Disease	cholesterol in large VLDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	6.37e-05	65	97	4	EFO_0021902
Disease	cholesterol in very large VLDL measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	6.37e-05	65	97	4	EFO_0022230
Disease	total lipids in small VLDL	TDRD15 HLA-DRB1 IGF2R CELSR2	7.18e-05	67	97	4	EFO_0022148
Disease	longevity, healthspan, parental longevity	HLA-DRB1 DEF8 CELSR2	1.18e-04	29	97	3	EFO_0004300, EFO_0007796, EFO_0009762
Disease	autism spectrum disorder (implicated_via_orthology)	TMPRSS9 NLGN4Y CHD7 OPRM1 NLGN4X	1.49e-04	152	97	5	DOID:0060041 (implicated_via_orthology)
Disease	pemphigus (is_implicated_in)	HLA-DRB1 CD40	2.22e-04	7	97	2	DOID:9182 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2 TNKS2	2.23e-04	260	97	6	EFO_0008317
Disease	Autistic Disorder	RELN HLA-DRB1 GRIK2 CSMD3 NLGN4X NPAS2	2.28e-04	261	97	6	C0004352
Disease	sleep duration, low density lipoprotein cholesterol measurement	TDRD15 ZHX3 IGF2R CELSR2	2.36e-04	91	97	4	EFO_0004611, EFO_0005271
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 CELSR2	2.96e-04	8	97	2	EFO_0008589, EFO_0008595
Disease	X-17676 measurement	DNAH3 TAS1R2	2.96e-04	8	97	2	EFO_0800785
Disease	autistic disorder (is_implicated_in)	RELN HLA-DRB1 NLGN4X	3.60e-04	42	97	3	DOID:12849 (is_implicated_in)
Disease	low affinity immunoglobulin epsilon Fc receptor measurement	HLA-DRB1 CD40	3.79e-04	9	97	2	EFO_0008210
Disease	PITUITARY DWARFISM I	POC1A WDR4	3.79e-04	9	97	2	C0342573
Disease	HMG CoA reductase inhibitor use measurement	TDRD15 ZHX3 CTRB2 CELSR2 CTRB1	4.09e-04	189	97	5	EFO_0009932
Disease	familial hyperlipidemia	TDRD15 HLA-DRB1 IGF2R CELSR2	4.22e-04	106	97	4	MONDO_0001336
Disease	interleukin 7 measurement	CCDC71L PARP8 NPAS2	4.42e-04	45	97	3	EFO_0008189
Disease	omega-6 polyunsaturated fatty acid measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2	4.94e-04	197	97	5	EFO_0005680
Disease	pathological myopia	PARP8 CLSTN2 NAV3 DNAH9	5.02e-04	111	97	4	EFO_0004207
Disease	lipoprotein A measurement	TDRD15 IGF2R CELSR2 SYTL3	5.19e-04	112	97	4	EFO_0006925
Disease	total lipids in lipoprotein particles measurement	TDRD15 HLA-DRB1 CELSR2	5.35e-04	48	97	3	EFO_0022309
Disease	free cholesterol measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	5.37e-04	113	97	4	EFO_0008591
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	5.55e-04	114	97	4	EFO_0004574, EFO_0004611
Disease	cholesterol in medium LDL measurement	HLA-DRB1 IGF2R CELSR2	5.69e-04	49	97	3	EFO_0022224
Disease	cholesterol in small LDL measurement	HLA-DRB1 IGF2R CELSR2	5.69e-04	49	97	3	EFO_0022227
Disease	cholesteryl esters to total lipids in small VLDL percentage	TDRD15 HLA-DRB1 CELSR2	5.69e-04	49	97	3	EFO_0022256
Disease	trypsin-2 measurement	CTRB2 CTRB1	5.77e-04	11	97	2	EFO_0008305
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	TDRD15 ZHX3 CELSR2	6.40e-04	51	97	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	phospholipids in medium VLDL measurement	HLA-DRB1 IGF2R CELSR2	6.77e-04	52	97	3	EFO_0022154
Disease	total lipids in medium LDL	HLA-DRB1 IGF2R CELSR2	6.77e-04	52	97	3	EFO_0022180
Disease	age-related hearing impairment	TMPRSS9 NAPEPLD HLA-DRB1 CLSTN2 CSMD3 CPNE1	7.16e-04	324	97	6	EFO_0005782
Disease	cholesterol in small VLDL measurement	HLA-DRB1 IGF2R CELSR2	7.16e-04	53	97	3	EFO_0022228
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2	7.34e-04	215	97	5	EFO_0008317, EFO_0008591
Disease	cholesterol to total lipids in very large VLDL percentage	TDRD15 HLA-DRB1 CELSR2	7.56e-04	54	97	3	EFO_0022244
Disease	triglycerides in medium VLDL measurement	TDRD15 HLA-DRB1 CELSR2	7.98e-04	55	97	3	EFO_0022155
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	TDRD15 HLA-DRB1 IGF2R CELSR2	8.08e-04	126	97	4	EFO_0004611, EFO_0010351
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	TDRD15 HLA-DRB1 IGF2R CELSR2 TNKS2	8.82e-04	224	97	5	EFO_0004530, EFO_0008317
Disease	total lipids in large LDL	TDRD15 IGF2R CELSR2	8.86e-04	57	97	3	EFO_0022163
Disease	cholesterol in large LDL measurement	TDRD15 IGF2R CELSR2	8.86e-04	57	97	3	EFO_0021901
Disease	diffuse plaque measurement	CCDC71L TMPRSS9 RELN GRIK2 CSMD3 OPRM1 CD40 NAV3 NPAS2	8.87e-04	758	97	9	EFO_0010699
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	TDRD15 ZHX3 HLA-DRB1 IGF2R CELSR2	8.99e-04	225	97	5	EFO_0008317, EFO_0010351
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 CELSR2	9.49e-04	14	97	2	EFO_0004611, EFO_0008589
Disease	phospholipids in small LDL measurement	TDRD15 IGF2R CELSR2	9.80e-04	59	97	3	EFO_0022297
Disease	free cholesterol to total lipids in very large VLDL percentage	TDRD15 HLA-DRB1 CELSR2	9.80e-04	59	97	3	EFO_0022289
Disease	response to statin, LDL cholesterol change measurement	TDRD15 CELSR2	1.09e-03	15	97	2	EFO_0007804, GO_0036273
Disease	serum metabolite measurement	TNPO1 TDRD15 POC1A HLA-DRB1 COL27A1 GRIK2 ZSCAN25 SLC22A24 IGF2R CELSR2	1.10e-03	945	97	10	EFO_0005653
Disease	cholesterol to total lipids in medium VLDL percentage	TDRD15 HLA-DRB1 CELSR2	1.19e-03	63	97	3	EFO_0022239
Disease	cholesteryl esters to total lipids in medium VLDL percentage	TDRD15 HLA-DRB1 CELSR2	1.24e-03	64	97	3	EFO_0022253
Disease	cochlin measurement	CCDC71L G2E3	1.25e-03	16	97	2	EFO_0801481
Disease	triglycerides in small LDL measurement	TDRD15 HLA-DRB1 CELSR2	1.30e-03	65	97	3	EFO_0022323
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 CELSR2	1.41e-03	17	97	2	EFO_0022232
Disease	total lipids in large VLDL	TDRD15 HLA-DRB1 CELSR2	1.42e-03	67	97	3	EFO_0022175
Disease	triglycerides in very small VLDL measurement	TDRD15 HLA-DRB1 IGF2R	1.48e-03	68	97	3	EFO_0022144
Disease	free cholesterol in large VLDL measurement	TDRD15 HLA-DRB1 CELSR2	1.48e-03	68	97	3	EFO_0022265
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	TDRD15 ZHX3 CELSR2	1.54e-03	69	97	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 CELSR2	1.58e-03	18	97	2	EFO_0008317, EFO_0008589
Disease	cholesteryl ester measurement	TDRD15 HLA-DRB1 IGF2R CELSR2 CD40	1.62e-03	257	97	5	EFO_0010351
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TDRD15 HLA-DRB1 IGF2R CELSR2	1.66e-03	153	97	4	EFO_0004611, EFO_0020944
Disease	unipolar depression, response to bupropion, mood disorder	ZHX3 NAV3	1.76e-03	19	97	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	ovulation	FAM227A KDM4A	1.76e-03	19	97	2	GO_0030728
Disease	colorectal cancer, inflammatory bowel disease	HLA-DRB1 GRIK2	1.76e-03	19	97	2	EFO_0003767, MONDO_0005575
Disease	renal system measurement	GRIK2 RGS14	1.96e-03	20	97	2	EFO_0004742
Disease	Colorectal Carcinoma	DNAH3 VPS18 PARP8 CLSTN2 CORO1B CSMD3 NLGN4X HR	2.22e-03	702	97	8	C0009402
Disease	response to anticonvulsant	TDRD15 CLSTN2 NAV3	2.80e-03	85	97	3	GO_0036277
Disease	lipoprotein measurement, phospholipid measurement	TDRD15 HLA-DRB1 CELSR2	2.80e-03	85	97	3	EFO_0004639, EFO_0004732
Disease	Autism Spectrum Disorders	RELN NLGN4X USH2A	2.80e-03	85	97	3	C1510586
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 HLA-DRB1 CELSR2	2.89e-03	86	97	3	EFO_0008595, EFO_0020945
Disease	liver fibrosis measurement	CCDC71L TDRD15 CELSR2	2.89e-03	86	97	3	EFO_0010576
Disease	Dwarfism	POC1A WDR4	3.05e-03	25	97	2	C0013336
Disease	serum gamma-glutamyl transferase measurement	TNPO1 SIPA1L3 CSMD3 ARPC1B CELSR2 NBEAL2 WBP4 CPNE1 FAM227A	3.17e-03	914	97	9	EFO_0004532

Protein segments in the cluster

Peptide	Gene	Start	Entry
PWQVSLQDKTGFHFC	CTRB2	46	Q6GPI1
PQSWFDTHEFKSDIC	FAM227A	261	F5H4B4
KRQEWAEPNSFHVCI	EP400	1181	Q96L91
RGFHCESSAHWPIFK	EIF3B	416	P55884
VRDNCHPFKATVLVW	COX18	161	Q8N8Q8
EVFAAWSDHRPVCKV	CSMD3	531	Q7Z407
FLVEPISCHAWNKDR	ARPC1B	6	O15143
WDSTFCAVNPKFLAV	CORO1B	36	Q9BR76
WVHRFCPQAAFVMKT	B3GALT5	141	Q9Y2C3
TEERTKPICVFWNHS	CELSR2	2311	Q9HCU4
VSFHPCIRFKRWESE	AP3M1	231	Q9Y2T2
AEEAALTCWKTFLHP	DHX32	526	Q7L7V1
TFRPAEFHWKLDQIC	CLSTN2	436	Q9H4D0
HERTFAFSFWPKDRV	CHD7	2301	Q9P2D1
RQCKWFVFDHDLVLP	LRRC9	601	Q6ZRR7
QWNSKPEFIVCTHSV	NPAS2	336	Q99743
VSFHPCVRFKRWESE	AP3M2	231	P53677
AAIASCKRAFPAWAD	ALDH6A1	81	Q02252
LSQHINWVRCAKFSP	POC1A	141	Q8NBT0
NLTRWTFEKACHPFL	TOR1AIP2	76	Q9H496
PETTFQTVSWHFCIA	OPRM1	311	P35372
WVVPNTDHVCTRFFF	PARP8	806	Q8N3A8
QTPREHSWISCKKEF	HHLA3	96	Q9XRX5
WSSLPCTKNRPFDFH	LONRF1	341	Q17RB8
DFTVNLPRFWESHAC	FUT9	321	Q9Y231
KTWLTRHSEQFECPR	HR	381	O43593
RIASPEEWHKVFSTC	OR51F1	236	A6NGY5
AHRFFDIKTWCCTSP	OR52B2	306	Q96RD2
AKVAASDWTFLHCLP	OTC	291	P00480
NFRWVLCANHTEPVK	NAV3	2171	Q8IVL0
NHSLWEPKVFAIRCF	EFR3B	261	Q9Y2G0
TQDPFCEWHQSTSRK	MEGF8	911	Q7Z7M0
DDWPFVVFITCFRHK	KDM4A	871	O75164
PSAAEVFKCVRWMHF	KBTBD7	256	Q8WVZ9
FWRFAAAPHICSDLK	PANX1	126	Q96RD7
NWLFFPGATVKHSCQ	RELN	371	P78509
FIHTKPNRFEEVAWS	NLGN4Y	546	Q8NFZ3
FTGNFASFCWDHRPV	G2E3	116	Q7L622
ENCWEEQTPGFKSHF	CEFIP	1021	Q711Q0
CFAQTVSPAEKWSVH	FSCN1	121	Q16658
PTCAQLFTSRKEHWI	DNAH3	406	Q8TD57
FSVLWNVPSAHCEAR	HYAL3	31	O43820
FLWQPKRECHFFNGT	HLA-DRB1	36	P01911
CKVQDGRWHQTLFTF	COL27A1	1811	Q8IZC6
TFPVTCLVDDWFVHK	MBOAT1	261	Q6ZNC8
CLVDDWFVHKASFPA	MBOAT1	266	Q6ZNC8
VWFDRFKITNDCPEH	LYPLAL1	76	Q5VWZ2
VHNWDFEPRKVSRCS	DEF8	321	Q6ZN54
ELWSFLCSLKHQFSP	CCDC71L	76	Q8N9Z2
SRKFPAIVNCTAIHW	DNAH9	2966	Q9NYC9
TVSSLQCNRHKPWRF	GRIK2	341	Q13002
KAHFWPRDLVAFSAQ	CERCAM	516	Q5T4B2
KTVRFQTPGRFSWFC	CCDC8	476	Q9H0W5
SPSEHRKWVEVFKAC	EFCAB11	16	Q9BUY7
FIHTKPNRFEEVAWS	NLGN4X	546	Q8N0W4
PWQVSLQDKTGFHFC	CTRB1	46	P17538
NPTWKRFSVPVQHFC	CPNE1	186	Q99829
PSAAEVFKCVRWMHF	KBTBD6	256	Q86V97
PRFGDHFEWNKVTSC	OSBPL7	626	Q9BZF2
FCFKLFHPLDQSVWA	OSBPL5	186	Q9H0X9
PSNTVWKIASDCFRF	NXT1	121	Q9UKK6
LFFSWHTPLACEQAT	IGF2R	1636	P11717
QACPQWKHSFVFSGV	SYTL3	526	Q4VX76
FAPWSLHSFRVQACT	USH2A	2296	O75445
DGLFSSHPSKRACFW	UTS2B	101	Q765I0
AIRFHCDPTFWAKNV	TRIM33	456	Q9UPN9
CTVFANDLNPESHKW	TRMT5	321	Q32P41
FERPFKDHQVCLEWN	SEL1L3	211	Q68CR1
TAAHCIFWKDTDPSI	PRSS29P	111	A6NIE9
VLENFTAFTPSHRCW	SLC22A24	36	Q8N4F4
NHFIEPVSCKLFSWT	TDRD15	866	B5MCY1
CLQKHFSRPSIWTQF	RGS20	11	O76081
IEKLCGHANWSQFRF	INSL6	41	Q9Y581
FQAFCATPEWRHFID	NBEAL2	1701	Q6ZNJ1
WIEEKTFCNAFPFHI	GUCY1B2	186	O75343
SRPWVCQKSFAHFDV	SIPA1L3	331	O60292
FSFPHKFEISFVIWC	SLC9A8	371	Q9Y2E8
ATKSRHSVQFVDWCP	TUBAL3	341	A6NHL2
HSVQFVDWCPTGFKV	TUBAL3	346	A6NHL2
VFQSHREFKEWFSNP	SRCAP	796	Q6ZRS2
TTEWPDCAKKRFANH	SVEP1	781	Q4LDE5
PICFKWFQIDAARGH	SLC39A2	26	Q9NP94
AFPIAKDRCVVAAFW	SNED1	91	Q8TER0
HSAEQCASIVFWKPT	CLEC6A	171	Q6EIG7
PCFTRAIEDWSHFVS	TEPP	181	Q6URK8
ERVTWNHFSPCHFLA	PWP1	346	Q13610
EFKDWNPSTARVHCF	WDR47	151	O94967
AWSEHRRHFPNCFFV	XIAP	216	P98170
SWKVFNERCRIHFKP	MIX23	126	Q4VC31
FQSSHRDFCFGPWKL	TIPRL	6	O75663
DEVKTHSSFWKPFQC	ZSCAN25	336	Q6NSZ9
ECFRTFLSSPRHKEW	VPS18	521	Q9P253
CKCWIADNRPSVEFH	WBP4	16	O75554
FWCAQFTAFPNLAKT	ZBED8	516	Q8IZ13
AAHCFNEFQDPTKWV	TMPRSS9	241	Q7Z410
FWKACERFQQIPASD	RGS14	96	O43566
IFFCDAVASWINPKD	TNPO1	841	Q92973
ACVNATDKWAFTPLH	TNKS2	736	Q9H2K2
CFKRQLVFLEWHEAP	TAS1R2	551	Q8TE23
CFSAKDWPQTFEKFH	TRAPPC9	86	Q96Q05
PQKFAASRIAFWCQE	WDR4	241	P57081
CHSGEASFVWNVAKP	ZHX3	131	Q9H4I2
PAGSVHKFTWLFENC	XIRP1	721	Q702N8
FSNVSSAFEKCHPWT	CD40	151	P25942
HDKVTFVFTPSQHWC	NAPEPLD	241	Q6IQ20